TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2011

Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901.

Thomas Shea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.